Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: A retrospective cohort study of 4,683 patients

被引:12
|
作者
Hong, Yi-Wen [1 ]
Lin, Jen-Der [2 ]
Yu, Ming-Chin [1 ]
Hsu, Chih-Chieh [1 ]
Lin, Yann-Sheng [1 ]
机构
[1] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Branch, Dept Surg, 5 Fuxing St, Taoyuan 333, Taiwan
[2] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Branch, Div Endocrinol & Metab,Dept Internal Med, 5 Fuxing St, Taoyuan 333, Taiwan
关键词
Thyroid cancer; Brain metastasis; Skull metastasis; Radioiodine; Surgery; BRAIN METASTASES; FOLLOW-UP; DISTANT METASTASIS; SKULL METASTASIS; CARCINOMA; PAPILLARY; RADIOIODINE; MANAGEMENT;
D O I
10.1016/j.ijsu.2018.06.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Cranial metastasis of thyroid cancer is rare. The aim of this study was to analyse the clinical characteristics, treatments and outcomes of thyroid cancer patients with cranial metastasis and to identify the associated prognostic factors. Materials and methods: Between January 1977 and August 2017, a total of 4683 patients were histologically confirmed to have thyroid cancer. Among them, 25 patients (0.53%) were identified as having cranial metastases, and their medical records were reviewed. The Kaplan-Meier method with a log-rank test was performed with cancer-specific survival as the main outcome. Cox regression analysis was used to examine the potential prognostic factors influencing patient survival. Results: Of the 25 patients, 21 were female, and 4 were male. The median age at the time of diagnosis of cranial metastasis was 63 years. Sixteen patients had metastases to the brain, and nine patients had metastases involving the skull only. Papillary carcinoma and follicular carcinoma accounted for 84.0% of cases. Twenty-four cases (96.0%) had extracranial metastases at the time of diagnosis of cranial metastases. Twenty patients received surgery, and 4 patients received palliative radiotherapy. One patient received supportive care only. The median cancer-specific survival after the diagnosis of cranial metastases was 27 months. According to the Kaplan-Meier test, 3 factors had a significant impact on survival, the metastatic site, histological types and surgical resection. According to the Cox regression analysis, skull metastases (HR: 0.274, 95% CI: 0.083-0.904, p = 0.033) and surgical resection (HR: 0.134, 95% CI: 0.019-0.929, p = 0.042) were identified as independent prognostic factors for a better outcome. Conclusions: Surgical resection is the mainstay therapy for thyroid cancer patients with cranial metastasis. Cranial metastases involving the skull only are associated with a better outcome.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 50 条
  • [41] Evaluating Current Prognostic Factors for Brain Metastases of Patients with Primary Lung and Breast Cancer Receiving Cranial Radiotherapy- A Single Center Study
    Yilmaz, Melek Tugce
    Kahvecioglu, Alper
    Yuce Sari, Sezin
    Gultekin, Melis
    Hurmuz, Pervin
    Zorlu, Faruk
    Yazici, Gozde
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2023, : 280 - 287
  • [42] Prognostic factors in patients with recurrent intrahepatic cholangiocarcinoma after curative resection: A retrospective cohort study
    Ohira, Masahiro
    Kobayashi, Tsuyoshi
    Hashimoto, Masakazu
    Tazawa, Hirofumi
    Abe, Tomoyuki
    Oshita, Akihiko
    Kohashi, Toshihiko
    Irei, Toshimitsu
    Oishi, Koichi
    Ohdan, Hideki
    INTERNATIONAL JOURNAL OF SURGERY, 2018, 54 : 156 - 162
  • [43] Comparable outcomes of nivolumab in patients with advanced NSCLC presenting with or without brain metastases: a retrospective cohort study
    Zhang, Guowei
    Cheng, Ruirui
    Wang, Huijuan
    Zhang, Yong
    Yan, Xiangtao
    Li, Peng
    Zhang, Mina
    Zhang, Xiaojuan
    Yang, Jinpo
    Niu, Yuanyuan
    Ma, Zhiyong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (03) : 399 - 405
  • [44] Prognostic factors and outcomes in COVID-19 patients requiring prolonged mechanical ventilation: a retrospective cohort study
    Melamed, Roman
    Paz, Francisco
    Jepsen, Stacy
    Smith, Claire
    Saavedra, Ramiro
    Mulder, Maximilian
    Masood, Adnan
    Huelster, Joshua
    Kirkland, Lisa
    Guenther, Alena
    Boland, Lori
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [45] Prevalence and predictors of thyroid cancer among thyroid nodules: a retrospective cohort study of 1,000 patients
    Elbalka, S. S.
    Metwally, I. H.
    Shetiwy, M.
    Awny, S.
    Hamdy, O.
    Kotb, S. Z.
    Shoman, A. M.
    Shahda, E.
    Elzahaby, I. A.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2021, 103 (09) : 683 - 689
  • [46] Risk factors for brain metastases in completely resected small cell lung cancer: a retrospective study to identify patients most likely to benefit from prophylactic cranial irradiation
    Zhu, Hui
    Bi, Yongmin
    Han, Anqin
    Luo, Jingyu
    Li, Minghuan
    Shi, Fang
    Kong, Li
    Yu, Jinming
    RADIATION ONCOLOGY, 2014, 9
  • [47] Prognostic factors in breast cancer patients with brain metastases
    Hakan Harputluoglu
    Omer Dizdar
    Kadri Altundag
    Journal of Neuro-Oncology, 2008, 87 : 193 - 193
  • [48] Obstetric outcomes in thyroid cancer survivors: A retrospective cohort study
    Liu, Dongming
    Wei, Yuan
    Zhao, Yangyu
    Li, Rong
    Yan, Jie
    Qiao, Jie
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2021, 155 (01) : 119 - 124
  • [49] Prognostic Factors for Bone Survival and Functional Outcomes in Patients With Breast Cancer Spine Metastases
    Qiao, Rui-Qi
    Zhang, Hao-Ran
    Ma, Rong-Xing
    Li, Rui-Feng
    Hu, Yong-Cheng
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [50] Prognostic factors of colorectal cancer patients with brain metastases
    Roussille, Pauline
    Auvray, Marie
    Vansteene, Damien
    Lecomte, Thierry
    Rigault, Eugenie
    Maillet, Marianne
    Locher, Christophe
    Dior, Marie
    Hautefeuille, Vincent
    Artru, Pascal
    Mabro, May
    Touchefeu, Yann
    Marthey, Lysiane
    Moulin, Valerie
    Louafi, Samy
    Lecaille, Cedric
    Chautard, Romain
    Lievre, Astrid
    Zaanan, Aziz
    Bennouna, Jaafar
    Berger, Antoine
    Emambux, Sheik
    Randrian, Violaine
    Tougeron, David
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : 67 - 73